Announcements Trials

Browse Landscape

Status

No longer available 1

Sponsor Class

Study Type

Interventional 9 Observational 2 Expanded_access 1

Sponsor

Cancer Type

NET 1 Endocrine 1

Conditions

Neuroendocrine Tumors 1

Interventions

Ga(III)-DOTATOC 2 surufatinib 1 lutetium Lu 177 dotatate 1 Gallium-68 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Expanded_access × surufatinib × NET × Clear all

NCT04814732 2024-04-12

Expanded Access Program of Surufatinib

Hutchmed

No longer available

Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡